Press release
Global Congestive Heart Failure (CHF) Market Outlook 2025-2034: Trends, Innovations, And Future Outlook
Congestive Heart Failure (CHF) Market Size
What Is the Congestive Heart Failure (CHF) Market Size and Projected Growth Rate?
The market scope for congestive heart failure (CHF) has seen robust augmentation in the past few years. The growth metrics show a burgeoning move from $15.94 billion in 2024 to $17.10 billion in 2025 with a compound annual growth rate (CAGR) of 7.2%. Factors spurring this growth over the historical years have been the greater frequency of the aging population, the uptick in cardiovascular diseases, increased awareness regarding heart health, expansion in healare spendings, and the burgeoning need for remote patient monitoring.
In the coming years, the congestive heart failure (CHF) market size is anticipated to experience substantial growth, expanding to $22.31 billion by 2029 with a compound annual growth rate (CAGR) of 6.9%. This growth during the forecast period is linked to numerous factors including an increased adoption of digital health technologies, elevated rates of hypertension, increasing obesity figures, enhanced patient results, and a heightened focus on personalized medicine. The forecast period will also witness significant trends such as progress in diagnostic technologies, improvement in treatment options, advancement in imaging technology, novel therapeutic strategies and the evolution of wearable health devices.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20730
What Are the Major Segments in the Congestive Heart Failure (CHF) Market?
The congestive heart failure (CHF) market covered in this report is segmented -
1) By Type: Systolic Heart Failure, Diastolic Failure, Left-Sided Heart Failure, Right-Sided Heart Failure
2) By Treatment: Medication, Surgery
3) By Diagnosis: Electrocardiogram, Echocardiogram, Magnetic Resonance Imaging (MRI), Stress Test, Blood Tests, Cardiac Catheterization, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare Settings
Subsegments:
1) By Systolic Heart Failure: Reduced Ejection Fraction (HFrEF), Mild-to-moderate Reduced Ejection Fraction
2) By Diastolic Heart Failure: Preserved Ejection Fraction (HFpEF), Borderline Ejection Fraction (HFpEF)
3) By Left-Sided Heart Failure: Acute Left-Sided Heart Failure, Chronic Left-Sided Heart Failure
4) By Right-Sided Heart Failure: Acute Right-Sided Heart Failure, Chronic Right-Sided Heart Failure
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20730&type=smp
What Are The Driving Congestive Heart Failure (CHF) Market Evolution?
The surge in number of cardiovascular patients is predicted to fuel the expansion of the congestive heart failure (CHF) market in the future. The term cardiovascular refers to the heart and blood vessels, focusing on their vital role in blood circulation and maintaining overall health. The growing number of cardiovascular patients is attributed to factors such as inactive lifestyles, unhealthy eating habits, aging populations, and urbanization, which in turn necessitates advanced healare and treatment solutions. Congestive heart failure (CHF) offers specific solutions for cardiovascular patients, enhancing heart efficiency, alleviating symptoms, and preventing complications, thus improving patient care and overall health. For example, the American College of Cardiology, a nonprofit medical society based in the US, reported a rise in cardiovascular disease cases to 19.8 million in 2022 as of January 2023. In addition, Eastern Europe records the highest mortality rate at 553 deaths per 100,000. As such, the rising number of cardiovascular patients is contributing to the growth of the congestive heart failure (CHF) market.
Which Firms Dominate The Congestive Heart Failure (CHF) Market Segments?
Major companies operating in the congestive heart failure (CHF) market are Pfizer Inc., Johnson & Johnson Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG., Medtronic Plc, Eli Lilly and Company, Canon Medical Systems Corporation, Novo Nordisk A/S, Jarvik Heart Inc., Boston Scientific Corporation, Applied Molecular Genetics Inc., Biotronik SE & Co. KG, Exelixis Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., LivaNova
What Trends Are Expected to Dominate the Acquired Autoimmune Hemolytic Anemia Market in the Next 5 Years?
Prominent companies in the congestive heart failure (CHF) market are turning to advanced technologies such as single intracoronary infusion methods with the aim to provide treatment measures that boost heart performance and elevate the lifestyle of CHF patients. Single intracoronary infusion supplies medication straight to the coronary artery, enabling targeted and accurate treatment for conditions like congestive heart failure (CHF). For example, in January 2024, Bayer AG, a pharmaceutical enterprise from Germany, and Asklepios Biopharmaceutical, Inc., a US-based biotech organization, launched the GenePHIT Phase II examination for AB-1002, an innovative gene therapy for congestive heart failure (CHF). This innovative solution uses a gene therapy methodology to target non-ischemic cardiomyopathy, suggesting a potential breakthrough in CHF treatment using cutting-edge genetic solutions. The trial is adjustable, double-blind, placebo-controlled, and plans to involve between 90 and 150 participants who have been medically stable for minimum four weeks and have a left ventricular ejection fraction from 15% to 35%.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/congestive-heart-failure-chf-global-market-report
Which Is The Largest Region In The Congestive Heart Failure (CHF) Market?
North America was the largest region in the congestive heart failure (CHF) market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congestive heart failure (CHF) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Congestive Heart Failure (CHF) Market?
2. What is the CAGR expected in the Congestive Heart Failure (CHF) Market?
3. What Are the Key Innovations Transforming the Congestive Heart Failure (CHF) Industry?
4. Which Region Is Leading the Congestive Heart Failure (CHF) Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Congestive Heart Failure (CHF) Market Outlook 2025-2034: Trends, Innovations, And Future Outlook here
News-ID: 4067666 • Views: …
More Releases from The Business Research Company
Ergonomic Office Chairs Market Size Forecast: $17.84 Billion by 2029 | Global Ou …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Projected Market Size Valuation of the Ergonomic Office Chairs Market by 2025?
The market size of ergonomic office chairs has experienced constant growth over the past few years. The market worth is anticipated to rise from $13.81 billion in 2024 to $14.49 billion in 2025, presenting a compound…
Carbon Composites Market Growth to be Driven by Emerging Trends | $28.25 Billion …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Carbon Composites Industry?
In the recent past, the carbon composites market has witnessed a significant expansion in its size. The market, worth $20.57 billion in 2024, is projected to rise to $21.71 billion in 2025, exhibiting a compound annual growth rate (CAGR) of…
Acrylic Surface Coating Industry Growth Outlook: 7.1% CAGR and $40.66 Billion by …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Acrylic Surface Coating Market Size 2025?
In recent times, there has been a substantial uptick in the growth of the acrylic surface coating market. The market is projected to expand from $29.11 billion in 2024 to $30.87 billion in 2025, showcasing a Compound Annual…
Global UV Inkjet Printing Market Expansion at 9.4% CAGR, Valued at $86.05 Billio …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the UV Inkjet Printing Market Size Forecast for 2025?
The market for UV inkjet printing has experienced substantial growth in recent years, with its value set to increase from $54.85 billion in 2024 to $60.09 billion in 2025. This translates to a compound annual growth rate (CAGR) of…
More Releases for CHF
Work-ID AG: Tackling the Skills Shortage with CHF 4 Million and Skills-Manager
Thalwil, June 25, 2025 - Work-ID AG has closed a successful CHF 4 million financing round. The Thalwil-based start-up is launching Skills-Manager, a tool that shows companies which people fit both professionally and personally. Selecting by age, appearance, or gender? That was yesterday. Skills are the hard currency for smart companies.
Skills-Manager reveals who is a real fit
With Skills-Manager, companies gain a tool to identify and leverage people's skills. They can…
Urgent Fundraising Campaign Launched to Pay CHF 4,000 Customs Fee and Reunite Mi …
Image: https://www.abnewswire.com/upload/2025/06/d380113ce38324782cf09e3032c4c76d.jpg
An urgent fundraising campaign has been launched by Miriam Schenk, a local resident facing a critical financial hurdle. With a CHF 4,000 customs bill standing between her and a package from her partner, a career soldier in the U.S. Army, Schenk is calling on kind-hearted donors, supporters, and philanthropists for assistance.
The package, sent by her boyfriend who is currently deployed, contains irreplaceable items of both emotional and financial value.…
Congestive Heart Failure (CHF) Treatment Devices Market Revenue Sizing Outlook A …
Allied Market Research added new research on Global Congestive Heart Failure (CHF) Treatment Devices Market- Global Opportunity Analysis and Industry Forecast, 2022-2030. The Congestive Heart Failure (CHF) Treatment Devices market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Some of the key…
Chronic Heart Failure (CHF) Drugs Industry Outlook and Forecast 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Chronic Heart Failure (CHF) Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Chronic Heart Failure (CHF) Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
GLOBAL INFO RESEARCH has lately published a new report titled, *Global Chronic Heart Failure (CHF) Drugs Market 2020 by Manufacturers, Regions,…
Screening Eagle raises CHF 55 million to protect the built world
Screening Eagle Technologies (SET), a cloud-based technology platform connecting sensors, software, and data for intelligent inspection of assets and infrastructure, is pleased to announce it has raised CHF 55 million in its first institutional round of equity funding.
Switzerland - April 3, 2020 -- Screening Eagle is on a mission to protect the built world. Massive economic value is at risk from aging global infrastructure and construction birth defects in…
Congestive Heart Failure (CHF) Treatment Devices Market Intelligence with Growin …
Global Congestive Heart Failure (CHF) Treatment Devices Market would reach $14.8 billion by 2022, at a CAGR of 5.5% from 2016 to 2022, according to a new report published by Allied Market Research.Implantable cardioverter-defibrillator (ICDs) segment is expected to dominate the global CHF treatment devices market throughout the forecast period. North America is projected to continue its lead in terms of revenue, accounting for more than two-fifths share of the…
